ID   PRRT1_RAT               Reviewed;         306 AA.
AC   Q6MG82;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 2.
DT   24-JUL-2024, entry version 101.
DE   RecName: Full=Proline-rich transmembrane protein 1;
DE   AltName: Full=Dispanin subfamily D member 1;
DE            Short=DSPD1;
DE   AltName: Full=Synapse differentiation-induced protein 4 {ECO:0000303|PubMed:26660156};
DE            Short=SynDIG4 {ECO:0000303|PubMed:26660156};
GN   Name=Prrt1 {ECO:0000312|RGD:1359348};
GN   Synonyms=Ng5 {ECO:0000312|EMBL:CAE83964.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:CAE83964.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway {ECO:0000312|EMBL:CAE83964.1};
RX   PubMed=15060004; DOI=10.1101/gr.1987704;
RA   Hurt P., Walter L., Sudbrak R., Klages S., Mueller I., Shiina T., Inoko H.,
RA   Lehrach H., Guenther E., Reinhardt R., Himmelbauer H.;
RT   "The genomic sequence and comparative analysis of the rat major
RT   histocompatibility complex.";
RL   Genome Res. 14:631-639(2004).
RN   [2]
RP   IDENTIFICATION IN AMPAR COMPLEX, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=22632720; DOI=10.1016/j.neuron.2012.03.034;
RA   Schwenk J., Harmel N., Brechet A., Zolles G., Berkefeld H., Muller C.S.,
RA   Bildl W., Baehrens D., Huber B., Kulik A., Klocker N., Schulte U.,
RA   Fakler B.;
RT   "High-resolution proteomics unravel architecture and molecular diversity of
RT   native AMPA receptor complexes.";
RL   Neuron 74:621-633(2012).
RN   [3]
RP   GENE FAMILY.
RX   PubMed=22363774; DOI=10.1371/journal.pone.0031961;
RA   Sallman Almen M., Bringeland N., Fredriksson R., Schioth H.B.;
RT   "The dispanins: a novel gene family of ancient origin that contains 14
RT   human members.";
RL   PLoS ONE 7:E31961-E31961(2012).
RN   [4]
RP   TOPOLOGY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=26660156; DOI=10.1002/cne.23945;
RA   Kirk L.M., Ti S.W., Bishop H.I., Orozco-Llamas M., Pham M., Trimmer J.S.,
RA   Diaz E.;
RT   "Distribution of the SynDIG4/proline-rich transmembrane protein 1 in rat
RT   brain.";
RL   J. Comp. Neurol. 524:2266-2280(2016).
CC   -!- FUNCTION: Required to maintain a pool of extrasynaptic AMPA-regulated
CC       glutamate receptors (AMPAR) which is necessary for synapse development
CC       and function. Regulates basal AMPAR function and synaptic transmission
CC       during development but is dispensable at mature hippocampal synapses.
CC       Plays a role in regulating basal phosphorylation levels of glutamate
CC       receptor GRIA1 and promotes GRIA1 and GRIA2 cell surface expression.
CC       {ECO:0000250|UniProtKB:O35449}.
CC   -!- SUBUNIT: Component of the outer core of AMPAR complex. AMPAR complex
CC       consists of an inner core made of 4 pore-forming GluA/GRIA proteins
CC       (GRIA1, GRIA2, GRIA3 and GRIA4) and 4 major auxiliary subunits arranged
CC       in a twofold symmetry. One of the two pairs of distinct binding sites
CC       is occupied either by CNIH2, CNIH3 or CACNG2, CACNG3. The other harbors
CC       CACNG2, CACNG3, CACNG4, CACNG8 or GSG1L. This inner core of AMPAR
CC       complex is complemented by outer core constituents binding directly to
CC       the GluA/GRIA proteins at sites distinct from the interaction sites of
CC       the inner core constituents. Outer core constituents include at least
CC       PRRT1, PRRT2, CKAMP44/SHISA9, FRRS1L and NRN1. The proteins of the
CC       inner and outer core serve as a platform for other, more peripherally
CC       associated AMPAR constituents. Alone or in combination, these auxiliary
CC       subunits control the gating and pharmacology of the AMPAR complex and
CC       profoundly impact their biogenesis and protein processing.
CC       {ECO:0000269|PubMed:22632720}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26660156,
CC       ECO:0000305|PubMed:22632720}; Single-pass type II membrane protein
CC       {ECO:0000305|PubMed:26660156}. Synapse {ECO:0000305|PubMed:22632720}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain (at protein level)
CC       (PubMed:22632720, PubMed:26660156). In brain, expressed in the
CC       neocortex and enriched in the hippocampus but only modestly expressed
CC       in the cerebellum (PubMed:26660156). Expressed throughout the
CC       hippocampus but is most highly expressed in the CA1 region and the
CC       stratum lacunosum-moleculare of the CA2 region (PubMed:26660156).
CC       {ECO:0000269|PubMed:22632720, ECO:0000269|PubMed:26660156}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low at postnatal day 0, increases at
CC       postnatal day 7, peaks at postnatal days 14 and 21 and decreases at 2
CC       months of age. {ECO:0000269|PubMed:26660156}.
CC   -!- SIMILARITY: Belongs to the CD225/Dispanin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAE83964.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX883044; CAE83964.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; NP_001027456.1; NM_001032285.1.
DR   AlphaFoldDB; Q6MG82; -.
DR   BioGRID; 268233; 1.
DR   CORUM; Q6MG82; -.
DR   IntAct; Q6MG82; 1.
DR   MINT; Q6MG82; -.
DR   STRING; 10116.ENSRNOP00000000495; -.
DR   PhosphoSitePlus; Q6MG82; -.
DR   SwissPalm; Q6MG82; -.
DR   PaxDb; 10116-ENSRNOP00000000495; -.
DR   ABCD; Q6MG82; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000000495.7; ENSRNOP00000000495.4; ENSRNOG00000000433.7.
DR   Ensembl; ENSRNOT00055010914; ENSRNOP00055008498; ENSRNOG00055006687.
DR   Ensembl; ENSRNOT00060012140; ENSRNOP00060009156; ENSRNOG00060007386.
DR   Ensembl; ENSRNOT00065047862; ENSRNOP00065039271; ENSRNOG00065027769.
DR   GeneID; 406167; -.
DR   KEGG; rno:406167; -.
DR   UCSC; RGD:1359348; rat.
DR   AGR; RGD:1359348; -.
DR   CTD; 80863; -.
DR   RGD; 1359348; Prrt1.
DR   eggNOG; ENOG502QWCK; Eukaryota.
DR   GeneTree; ENSGT00940000162382; -.
DR   HOGENOM; CLU_096299_0_0_1; -.
DR   InParanoid; Q6MG82; -.
DR   OMA; HHDNDWG; -.
DR   OrthoDB; 2919628at2759; -.
DR   PhylomeDB; Q6MG82; -.
DR   TreeFam; TF331357; -.
DR   PRO; PR:Q6MG82; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000433; Expressed in cerebellum and 20 other cell types or tissues.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISO:RGD.
DR   GO; GO:0030545; F:signaling receptor regulator activity; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0060292; P:long-term synaptic depression; ISS:UniProtKB.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0034394; P:protein localization to cell surface; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; ISS:UniProtKB.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   InterPro; IPR051423; CD225/Dispanin.
DR   InterPro; IPR007593; CD225/Dispanin_fam.
DR   PANTHER; PTHR14948; NG5; 1.
DR   PANTHER; PTHR14948:SF21; PROLINE-RICH TRANSMEMBRANE PROTEIN 1; 1.
DR   Pfam; PF04505; CD225; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Membrane; Reference proteome; Signal-anchor; Synapse;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..306
FT                   /note="Proline-rich transmembrane protein 1"
FT                   /id="PRO_0000299077"
FT   TOPO_DOM        1..223
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:26660156"
FT   TRANSMEM        224..244
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        245..275
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:26660156"
FT   INTRAMEM        276..296
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        297..306
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:26660156"
FT   REGION          1..144
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        12..37
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        82..106
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        118..142
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   306 AA;  31389 MW;  4A5C2A23A33E2116 CRC64;
     MSSEKSGLPD SVPHTSPPPY NAPQPPAEPP IPPPQTAPSS HHHHHHHYHQ SGTATLPRLG
     AGGLASAAAG AQRGPSSSAT LPRPPHHAPP GPAAGAPPPG CATLPRMPPD PYLQETRFEG
     PLPPPPPAAA APPPPAPAPT AQAPGFVVPT HAGAVGTLPL GGYVAPGYPL QLQPCTAYVP
     VYPVGTPYAS GTPGGPGVTS TLPPPPQGPG LALLEPRRPP HDYMPIAVLT TICCFWPTGI
     IAIFKAVQVR TALARGDLVS AEIASREARN FSFISLAVGI AAMVLCTILT VVIIIAAQHH
     ENYWDP
//
